Cancer Drugs Fund requires further reform.

Grieve, R. ; Abrams, K. ; Claxton, K. ; Goldacre, B. ; James, N. ; Nicholl, J. ; Parmar, M. ; Parker, C. ; Sekhon, J.S. ; Smeeth, L. ; Spiegelhalter, D. ; Sculpher, M. ;
Cancer Drugs Fund requires further reform.
BMJ, 2016; 354:i5090